HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hyperthermia associated with 3,4-methylenedioxyethamphetamine ('Eve').

Abstract
A patient was admitted with hyperthermia, muscle rigidity, rhabdomyolysis and disseminated intravascular coagulation. He was initially thought to have taken 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), but subsequent toxicology revealed the presence of 3,4-methylenedioxyethamphetamine (MDEA, 'Eve'), its sister drug, in his blood. Subsequent in vitro testing for malignant hyperthermia proved to be negative.
AuthorsB Tehan, R Hardern, A Bodenham
JournalAnaesthesia (Anaesthesia) Vol. 48 Issue 6 Pg. 507-10 (Jun 1993) ISSN: 0003-2409 [Print] England
PMID8322992 (Publication Type: Case Reports, Journal Article, Review)
Chemical References
  • Designer Drugs
  • 3,4-Methylenedioxyamphetamine
  • 3,4-methylenedioxyethamphetamine
Topics
  • 3,4-Methylenedioxyamphetamine (analogs & derivatives, poisoning)
  • Adult
  • Designer Drugs (poisoning)
  • Fever (chemically induced)
  • Humans
  • Male
  • Poisoning (therapy)
  • Substance-Related Disorders

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: